PubRank

Shigeru Marubashi

Author PubWeight™ 94.13‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma. J Hepatol 2011 2.18
2 Preoperative gemcitabine-based chemoradiation therapy for resectable and borderline resectable pancreatic cancer. Ann Surg 2013 2.17
3 Involvement of ribonucleotide reductase M1 subunit overexpression in gemcitabine resistance of human pancreatic cancer. Int J Cancer 2007 1.77
4 Patterns and clinicopathologic features of extrahepatic recurrence of hepatocellular carcinoma after curative resection. Surgery 2007 1.75
5 Intragraft transcriptome level of CXCL9 as biomarker of acute cellular rejection after liver transplantation. J Surg Res 2012 1.39
6 Interferon-alpha and 5-fluorouracil combination therapy after palliative hepatic resection in patients with advanced hepatocellular carcinoma, portal venous tumor thrombus in the major trunk, and multiple nodules. Cancer 2007 1.31
7 Angiogenesis in cholangiocellular carcinoma: expression of vascular endothelial growth factor, angiopoietin-1/2, thrombospondin-1 and clinicopathological significance. Oncol Rep 2006 1.28
8 Thrombendvenectomy for organized portal vein thrombosis at the time of liver transplantation. Ann Surg 2002 1.24
9 Clinical and pathological features of Allen's type C classification of resected combined hepatocellular and cholangiocarcinoma: a comparative study with hepatocellular carcinoma and cholangiocellular carcinoma. J Gastrointest Surg 2006 1.19
10 Participation of autophagy in the degeneration process of rat hepatocytes after transplantation following prolonged cold preservation. Arch Histol Cytol 2005 1.14
11 Assessment of the severity of liver disease and fibrotic change: the usefulness of hepatic CT perfusion imaging. Oncol Rep 2006 1.13
12 Partial contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/TRAIL receptor pathway to antitumor effects of interferon-alpha/5-fluorouracil against Hepatocellular Carcinoma. Clin Cancer Res 2004 1.11
13 Combination of IFN-alpha and 5-fluorouracil induces apoptosis through IFN-alpha/beta receptor in human hepatocellular carcinoma cells. Clin Cancer Res 2005 1.11
14 Role of crosstalk between interleukin-6 and transforming growth factor-beta 1 in epithelial-mesenchymal transition and chemoresistance in biliary tract cancer. Eur J Cancer 2013 1.07
15 Equivalent outcomes after anatomical and non-anatomical resection of small hepatocellular carcinoma in patients with preserved liver function. Dig Dis Sci 2012 1.02
16 Hepatic resection followed by IFN-alpha and 5-FU for advanced hepatocellular carcinoma with tumor thrombus in the major portal branch. Hepatogastroenterology 2007 1.02
17 De novo tumors after liver transplantation: a single-institution experience. Liver Transpl 2002 1.00
18 Molecular mapping of human hepatocellular carcinoma provides deeper biological insight from genomic data. Eur J Cancer 2008 0.99
19 IGFBP7 downregulation is associated with tumor progression and clinical outcome in hepatocellular carcinoma. Int J Cancer 2011 0.99
20 Role of the Fas/FasL pathway in combination therapy with interferon-alpha and fluorouracil against hepatocellular carcinoma in vitro. J Hepatol 2006 0.98
21 A single-incision laparoscopic hepatectomy for hepatocellular carcinoma: initial experience in a Japanese patient. Minim Invasive Ther Allied Technol 2010 0.97
22 Molecular prediction of early recurrence after resection of hepatocellular carcinoma. Eur J Cancer 2009 0.96
23 Combination therapy of interferon-alpha and 5-fluorouracil inhibits tumor angiogenesis in human hepatocellular carcinoma cells by regulating vascular endothelial growth factor and angiopoietins. Oncol Rep 2007 0.96
24 Expression of Id proteins in human hepatocellular carcinoma: relevance to tumor dedifferentiation. Int J Oncol 2005 0.96
25 Increased immunogenicity of tumor-associated antigen, mucin 1, engineered to express alpha-gal epitopes: a novel approach to immunotherapy in pancreatic cancer. Cancer Res 2010 0.96
26 Role of the hypoxia-related gene, JMJD1A, in hepatocellular carcinoma: clinical impact on recurrence after hepatic resection. Ann Surg Oncol 2011 0.96
27 Complete remission of hepatocellular carcinoma with portal vein tumor thrombus and lymph node metastases by arterial infusion of 5-fluorouracil and interferon-alpha combination therapy following hepatic resection. J Gastroenterol 2007 0.96
28 Involvement of microRNA-181b in the gemcitabine resistance of pancreatic cancer cells. Pancreatology 2013 0.95
29 Prognosis of hepatocellular carcinoma with biliary tumor thrombi after liver surgery. Surgery 2011 0.95
30 miR-146a suppresses the sensitivity to interferon-α in hepatocellular carcinoma cells. Biochem Biophys Res Commun 2011 0.95
31 Clinical significance of surgical resection of metastatic lymph nodes from hepatocellular carcinoma. Surg Today 2014 0.94
32 Interferon alpha receptors are important for antiproliferative effect of interferon-alpha against human hepatocellular carcinoma cells. Hepatol Res 2007 0.94
33 Sclerosing epithelioid fibrosarcoma of the liver infiltrating the inferior vena cava. World J Gastroenterol 2009 0.94
34 Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography in differential diagnosis of benign and malignant intraductal papillary-mucinous neoplasm of the pancreas. Oncol Rep 2010 0.94
35 Use of a metallic-wall stent in the magnet compression anastomosis technique for bile duct obstruction after liver transplantation. Liver Transpl 2008 0.93
36 Combined transplantation of pancreatic islets and adipose tissue-derived stem cells enhances the survival and insulin function of islet grafts in diabetic mice. Transplantation 2010 0.93
37 Mural nodule in branch duct-type intraductal papillary mucinous neoplasms of the pancreas is a marker of malignant transformation and indication for surgery. Am J Surg 2011 0.93
38 Long-term outcome of combined interferon-α and 5-fluorouracil treatment for advanced hepatocellular carcinoma with major portal vein thrombosis. Oncology 2011 0.93
39 Pilot study of combination chemotherapy of S-1, a novel oral DPD inhibitor, and interferon-alpha for advanced hepatocellular carcinoma with extrahepatic metastasis. Cancer 2008 0.91
40 Pretreatment with S-1, an oral derivative of 5-fluorouracil, enhances gemcitabine effects in pancreatic cancer xenografts. Anticancer Res 2008 0.91
41 A case of hepatocellular carcinoma with multiple lung, spleen, and remnant liver metastasis successfully treated by combination chemotherapy with the novel oral DPD-inhibiting chemotherapeutic drug S-1 and interferon-alpha. J Gastroenterol 2006 0.90
42 Incidence and recurrence of autoimmune/alloimmune hepatitis in liver transplant recipients. Liver Transpl 2002 0.90
43 Surgical outcomes of noninvasive and minimally invasive intraductal papillary-mucinous neoplasms of the pancreas. Ann Surg Oncol 2006 0.90
44 A thick pancreas is a risk factor for pancreatic fistula after a distal pancreatectomy: selection of the closure technique according to the thickness. Dig Surg 2011 0.90
45 Correlation between intraoperative blood flows and hepatic artery strictures in liver transplantation. Liver Transpl 2002 0.90
46 Hepatectomy based on the tumor hemodynamics for hepatocellular carcinoma: a comparison among the hybrid and pure laparoscopic procedures and open surgery. Surg Endosc 2012 0.89
47 Association between recurrence of hepatocellular carcinoma and alpha-fetoprotein messenger RNA levels in peripheral blood. Surg Today 2005 0.88
48 PLOD2 induced under hypoxia is a novel prognostic factor for hepatocellular carcinoma after curative resection. Liver Int 2011 0.88
49 Clinicopathological features of recurrence in patients after 10-year disease-free survival following curative hepatic resection of hepatocellular carcinoma. World J Surg 2013 0.88
50 Combination of interferon-alpha and 5-fluorouracil inhibits endothelial cell growth directly and by regulation of angiogenic factors released by tumor cells. BMC Cancer 2009 0.87
51 Preoperative chemoradiotherapy, surgery and adjuvant therapy for resectable pancreatic cancer. Hepatogastroenterology 2013 0.87
52 Gene expression profiling of acute cellular rejection in rat liver transplantation using DNA microarrays. Liver Transpl 2009 0.86
53 Differential transcriptome patterns for acute cellular rejection in recipients with recurrent hepatitis C after liver transplantation. Liver Transpl 2009 0.85
54 Tyrosine kinase inhibitor PTK/ZK enhances the antitumor effects of interferon-α/5-fluorouracil therapy for hepatocellular carcinoma cells. Ann Surg Oncol 2010 0.85
55 Experience with the use of fibrin sealant plus polyglycolic acid felt at the cut surface of the liver in laparoscopic hepatectomy. Surg Endosc 2011 0.84
56 Significant improvement in islet yield and survival with modified ET-Kyoto solution: ET-Kyoto/Neutrophil elastase inhibitor. Cell Transplant 2012 0.83
57 TGF-beta1-induced cell growth arrest and partial differentiation is related to the suppression of Id1 in human hepatoma cells. Oncol Rep 2006 0.83
58 Overexpression of MT3-MMP in hepatocellular carcinoma correlates with capsular invasion. Hepatogastroenterology 2007 0.83
59 Fresh frozen plasma transfusion does not affect outcomes following hepatic resection for hepatocellular carcinoma. World J Gastroenterol 2010 0.82
60 Diagnostic laparoscopy with 5-aminolevulinic-acid-mediated photodynamic diagnosis enhances the detection of peritoneal micrometastases in advanced gastric cancer. Oncology 2014 0.82
61 Serum neutrophil gelatinase associated lipocalin during the early postoperative period predicts the recovery of graft function after kidney transplantation from donors after cardiac death. J Urol 2012 0.82
62 Treatment of unresectable hepatoblastoma with liver transplantation in the pediatric population. Am J Transplant 2002 0.82
63 Comparison of postoperative morphological changes in remnant pancreas between pancreaticojejunostomy and pancreaticogastrostomy after pancreaticoduodenectomy. Pancreas 2009 0.82
64 Expression of type I interferon receptor as a predictor of clinical response to interferon-alpha therapy of gastrointestinal cancers. Oncol Rep 2006 0.82
65 Novel therapeutic target for cancer stem cells in hepatocellular carcinoma. J Hepatobiliary Pancreat Sci 2012 0.81
66 Combined IFN-α and 5-FU treatment as a postoperative adjuvant following surgery for hepatocellular carcinoma with portal venous tumor thrombus. Exp Ther Med 2012 0.81
67 Isolated metastasis to the gallbladder from hepatocellular carcinoma. Hepatol Res 2010 0.80
68 Successful outcome after resection of liver metastasis arising from an extraadrenal retroperitoneal paraganglioma that appeared 9 years after surgical excision of the primary lesion. Int J Clin Oncol 2009 0.80
69 Clinicopathological features of long-term survivors for advanced biliary tract cancer and impact of the number of lymph nodes involved. Int J Surg 2013 0.80
70 [A case of long-term survivor with multiple pulmonary metastases of HCC after hepatic resection]. Gan To Kagaku Ryoho 2004 0.80
71 Prediction of the postoperative prognosis of intrahepatic cholangiocarcinoma (ICC): importance of preoperatively- determined anatomic invasion level and number of tumors. Dig Dis Sci 2014 0.79
72 Advantage of autologous blood transfusion in surgery for hepatocellular carcinoma. World J Gastroenterol 2011 0.79
73 The long-term outcomes after curative resection for mass-forming intrahepatic cholangiocarcinoma associated with hepatitis C viral infection: a multicenter analysis by Osaka Hepatic Surgery Study Group. J Surg Oncol 2014 0.79
74 [A long-term survival case of hepatocellular carcinoma recurrence after the patient received a living donor liver transplantation treated by combined modality therapy]. Gan To Kagaku Ryoho 2008 0.79
75 [A case of synchronous triple cancer involving advanced hepatocellular carcinoma]. Gan To Kagaku Ryoho 2008 0.79
76 Utilization of autologous vein graft for replacement of the inferior vena cava in living-donor liver transplantation for obliterative hepatocavopathy. Transpl Int 2007 0.79
77 Xenon-inhalation computed tomography for noninvasive quantitative measurement of tissue blood flow in pancreatic tumor. Dig Dis Sci 2011 0.78
78 Synergistic antitumor effect of interferon-ß with gemcitabine in interferon-α-non-responsive pancreatic cancer cells. Int J Oncol 2011 0.78
79 Quantitative tissue blood flow measurement of the liver parenchyma: comparison between xenon CT and perfusion CT. Dig Dis Sci 2007 0.78
80 Treatment of borderline cases for curative resection of biliary tract cancer. J Surg Oncol 2011 0.78
81 A multi-institution phase II study of gemcitabine/cisplatin/S-1 (GCS) combination chemotherapy for patients with advanced biliary tract cancer (KHBO 1002). Cancer Chemother Pharmacol 2014 0.78
82 [A case of successful surgical resection followed by S-1 administration for hepatocellular carcinoma with lung metastases and a tumor thrombus into right atrium]. Gan To Kagaku Ryoho 2011 0.78
83 Significance of alanine aminopeptidase N (APN) in bile in the diagnosis of acute cellular rejection after liver transplantation. J Surg Res 2011 0.78
84 Vitamin K2 has growth inhibition effect against hepatocellular carcinoma cell lines but does not enhance anti-tumor effect of combination treatment of interferon-alpha and fluorouracil in vitro. Hepatol Res 2006 0.78
85 [A case of resected liver metastasis from rectal cancer with bile duct stricture after radiofrequency ablation]. Gan To Kagaku Ryoho 2014 0.78
86 [A case of successful multimodal treatment for combined hepatocellular and cholangiocarcinoma with portal venous tumor thrombus]. Gan To Kagaku Ryoho 2009 0.78
87 Multidetector computed tomography for preoperative prediction of postsurgical prognosis of patients with extrahepatic biliary cancer. J Surg Oncol 2010 0.78
88 Effects of pre-operative transcatheter arterial chemoembolization for resectable hepatocellular carcinoma: Implication of circulating cancer cells by detection of α-fetoprotein mRNA. Exp Ther Med 2010 0.77
89 PTK787/ZK222584 combined with interferon alpha and 5-fluorouracil synergistically inhibits VEGF signaling pathway in hepatocellular carcinoma. Ann Surg Oncol 2013 0.77
90 [Complete Surgical Resection of a Huge Hepatocellular Carcinoma Invading the Diaphragm and Lung after Transcatheter Arterial Chemoembolization(TACE)and Sorafenib-A Case Report]. Gan To Kagaku Ryoho 2015 0.77
91 [A case of hepatocellular carcinoma with right atrium tumor thrombus treated with combined doxorubicin and interferon-beta/intra-arterial injection chemotherapy and hepatectomy]. Gan To Kagaku Ryoho 2007 0.77
92 [A long-term survival case of pancreatic cancer with hepatic metastasis after pancreaticoduodenectomy successfully treated by s-1 and gemcitabine combination chemotherapy]. Gan To Kagaku Ryoho 2009 0.77
93 [A case of locally advanced pancreatic cancer with superior membrane artery invasion successfully resected after gemcitabine-based chemoradiotherapy]. Gan To Kagaku Ryoho 2009 0.77
94 Diagnostic value of FDG-PET for lymph node metastasis and outcome of surgery for biliary cancer. J Surg Oncol 2010 0.77
95 [A case of successful second look operation for hepatocellular carcinoma with right atrial tumor thrombus]. Gan To Kagaku Ryoho 2011 0.77
96 Upregulation of nuclear PA28γ expression in cirrhosis and hepatocellular carcinoma. Exp Ther Med 2011 0.77
97 [Surgical treatment for peritoneal seeding and needle-tract implantation of hepatocellular carcinoma after ultrasound-guided percutaneous puncture]. Gan To Kagaku Ryoho 2007 0.77
98 Erratum: Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer. Nat Genet 2016 0.77
99 Clinical value of alterations in p73 gene, related to p53 at 1p36, in human hepatocellular carcinoma. Int J Oncol 2004 0.77
100 Fibrin sealant with PGA felt for prevention of bile leakage after liver resection. Hepatogastroenterology 2012 0.77
101 [Comparison of early clinical outcomes between laparoscopic total gastrectomy and open total gastrectomy for early-stage gastric cancer]. Gan To Kagaku Ryoho 2014 0.76
102 [Usefulness of laparoscopy endoscopy cooperative surgery for gastric gastrointestinal stromal tumor]. Gan To Kagaku Ryoho 2014 0.76
103 Prognostic impact of tumoral and/or peri-tumoral stromal SPARC expressions after surgery in patients with biliary tract cancer. J Surg Oncol 2014 0.76
104 Impact of postoperative irradiation after non-curative resection of hilar biliary cancer. J Surg Oncol 2009 0.76
105 Guanylate-binding protein 2 mRNA in peripheral blood leukocytes of liver transplant recipients as a marker for acute cellular rejection. Transpl Int 2009 0.76
106 Reconstruction of the middle hepatic vein in a modified right liver graft of living-donor liver transplantation while preserving the recipient's middle hepatic vein. Transpl Int 2005 0.75
107 [A case report of port-site metastasis of pancreatic cancer after laparoscope assistted distal pancreatectomy]. Gan To Kagaku Ryoho 2011 0.75
108 Arterial stimulation and venous sampling for glucagonomas of the pancreas. Hepatogastroenterology 2012 0.75
109 Effect of in vivo administration of reprogramming factors in the mouse liver. Oncol Lett 2013 0.75
110 ABO-incompatible adult liver transplantation when the anti-ABO antibody titer is high. Hepatogastroenterology 2009 0.75
111 [Multiple extracranial metastases from meningioma treated with surgical resection - a case report]. Gan To Kagaku Ryoho 2014 0.75
112 [A case of curative resected hilar bile duct cancer with hepatic artery and portal vein reconstructions]. Gan To Kagaku Ryoho 2010 0.75
113 [A case of initially unresectable pancreatic cancer with arterial invasion successfully resected after chemotherapy]. Gan To Kagaku Ryoho 2014 0.75
114 [Self-expandable metallic stent therapy for obstructive colon cancer]. Gan To Kagaku Ryoho 2014 0.75
115 [A case of successful treatment by interferon-α and 5-fluorouracil combination therapy (FAIT) and transcatheter arterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus]. Gan To Kagaku Ryoho 2011 0.75
116 [Successful treatment of advanced gallbladder cancer involving the extrahepatic bile duct with neoadjuvant chemoradiation therapy - a case report]. Gan To Kagaku Ryoho 2014 0.75
117 Early plasma exchange for progressive liver failure in recipients of adult-to-adult living-related liver transplants. Blood Purif 2009 0.75
118 [Irradiation with carbon ions for locally recurrent rectal cancer]. Gan To Kagaku Ryoho 2014 0.75
119 [A case of hepatocellular carcinoma with gall bladder metastasis]. Gan To Kagaku Ryoho 2008 0.75
120 [A case of pathological complete response with neoadjuvant mFOLFOX6 chemotherapy for advanced lower rectal cancer]. Gan To Kagaku Ryoho 2013 0.75
121 [Successful treatment of combined intraarterial (5-fluorouracil and adriamycin and cisplatin) infusion chemotherapy for advanced hepatocellular carcinoma with multiple intrahepatic metastases and/or portal vein thrombosis--two case reports]. Gan To Kagaku Ryoho 2005 0.75
122 Effects of preceding interferon therapy on outcome after surgery for hepatitis C virus-related hepatocellular carcinoma. J Surg Oncol 2010 0.75
123 [A case of hepatic resection after chemotherapy for metastatic colon cancer of the liver with invasion of the inferior vena cava and hepatic vein]. Gan To Kagaku Ryoho 2014 0.75
124 [A case of successful surgical resection after repeated transcatheter arterial chemoembolization for far advanced multiple hepatocellular carcinomas in both lobes associated with Vp₂ portal vein tumor thrombus]. Gan To Kagaku Ryoho 2011 0.75
125 [A case of HCC with inferior caval vein tumor thrombus and multiple pulmonary metastases that remarkably responded to combination therapy of TS-1 and interferon-alpha]. Gan To Kagaku Ryoho 2005 0.75
126 [A case of intrahepatic cholangiocarcinoma difficult to distinguish from metastatic liver cancer]. Gan To Kagaku Ryoho 2014 0.75
127 Higher complication rate in hepatocellular carcinoma patients undergoing prophylactic cholecystectomy with curative hepatic resection. Hepatogastroenterology 2014 0.75
128 [Current status and problem about cadaveric liver transplantation in Japan]. Nihon Shokakibyo Gakkai Zasshi 2011 0.75
129 [A case of long-term survival for advanced gallbladder cancer]. Gan To Kagaku Ryoho 2009 0.75
130 [A case report of total remnant pancreatectomy for ductal carcinoma after distal pancreatectomy for invasive intraductal papillary mucinous carcinoma]. Gan To Kagaku Ryoho 2012 0.75
131 Successful adult ABO incompatible living donor liver transplantation: experience with double infusion through the hepatic artery and portal vein. Hepatogastroenterology 2011 0.75
132 A safe protocol of intermittent hilar vascular clamping for hepatic resection in cirrhosis. Hepatogastroenterology 2009 0.75
133 [Management of pulmonary recurrence of hepatocellular carcinoma after receiving a living-donor liver transplantation--a case report]. Gan To Kagaku Ryoho 2008 0.75
134 [A successful surgical treatment for solitary pulmonary and adrenal metastases after hepatic resection to hepatocellular carcinoma--a case report]. Gan To Kagaku Ryoho 2005 0.75
135 [A case of advanced hepatocellular carcinoma with tumor thrombosis in the main trunk of the portal vein successfully treated by multidisciplinary therapies]. Gan To Kagaku Ryoho 2012 0.75
136 [Repeated occlusion of the intraperitoneal access port for intraperitoneal chemotherapy in a patient with gastric cancer with peritoneal dissemination]. Gan To Kagaku Ryoho 2013 0.75
137 [A case of complete response to interferon-α and S-1 combination therapy for multiple pulmonary recurrences of hepatocellular carcinoma after hepatic resection]. Gan To Kagaku Ryoho 2011 0.75
138 [A case of advanced multiple hepatocellular carcinomas in both lobes that achieved long-term survival after repeated transcatheter arterial chemoembolization and surgical resection]. Gan To Kagaku Ryoho 2012 0.75
139 [A case of hepatocellular carcinoma treated by transcatheter arterial chemoembolization and hepatectomy after subtotal stomach preserving pancreaticoduodenectomy for duodenal cancer]. Gan To Kagaku Ryoho 2012 0.75
140 [A long-term survival case of hepatocellular carcinoma with lymph node metastasis on the posterior surface of the pancreas head and portal vein tumor thrombus successfully treated with hepatopancreatoduodenectomy and adjuvant interferon-alpha and 5-fluorouracil combination therapy]. Gan To Kagaku Ryoho 2009 0.75
141 [A case of successful treatment of advanced hepatocellular carcinoma with tumor thrombi in the major portal branches and inferior vena cava with combined intraarterial 5-fluorouracil, adriamycin and cisplatin therapy]. Gan To Kagaku Ryoho 2003 0.75
142 [Intra arterial infusion chemotherapy combined with interferon-alpha following palliative hepatic resection against advanced hepatoma with portal venous tumor thrombus in the major trunk and multiple nodules--a preliminary study]. Gan To Kagaku Ryoho 2006 0.75
143 [A long-term survival case of hepatocellular carcinoma with portal vein and inferior vena cava tumor thrombi]. Gan To Kagaku Ryoho 2010 0.75
144 [Successful treatment for advanced cholangiocellular carcinoma with intrahepatic metastasis and/or portal vein tumor thrombi by intraarterial chemotherapy combined with 5-fluorouracil, adriamycin and cisplatin (FAP)--two cases report]. Gan To Kagaku Ryoho 2004 0.75
145 [A case of curatively resected intrahepatic cholangiocarcinoma with hepatic artery and portal vein reconstruction]. Gan To Kagaku Ryoho 2014 0.75
146 [Long-term survival in a case of advanced hepatocellular carcinoma with tumor thrombus in the portal vein and the right atrium (vp4,vv3 ) treated successfully with multidisciplinary therapies]. Gan To Kagaku Ryoho 2014 0.75
147 [A long-term survival case of hepatocellular carcinoma with bone metastasis and inferior vena cava tumor thrombus successfully treated with multidisciplinary therapy]. Gan To Kagaku Ryoho 2010 0.75
148 [A case of combined hepatocellular and cholangiocarcinoma showing tumor growth and invasion to the diaphragm during interferon-alpha and 5-fluorouracil combined intra-arterial chemotherapy]. Gan To Kagaku Ryoho 2008 0.75
149 Exploration of potential genomic portraits associated with intrahepatic recurrence in human hepatocellular carcinoma. Ann Surg Oncol 2010 0.75
150 Interstitial pneumonia induced by combined intraarterial 5-fluorouracil and subcutaneous interferon-alpha therapy for advanced hepatocellular carcinoma. J Gastroenterol 2004 0.75
151 [A case of intrahepatic cholangiocarcinoma with invasion to right adrenal gland]. Gan To Kagaku Ryoho 2011 0.75
152 [A Case of AFP and PIVKA- II Producing Gastric Cancer Presenting with Metachronous Multiple Liver Metastases]. Gan To Kagaku Ryoho 2016 0.75
153 [Surgical treatment for peritoneal dissemination of hepatocellular carcinoma after percutaneous ethanol injection therapy--a case report]. Gan To Kagaku Ryoho 2006 0.75
154 [A case of surgical resection for liver metastasis of gastric cancer with portal vein tumor thrombus]. Gan To Kagaku Ryoho 2014 0.75
155 [A case of long-term survival with TAE resistant multiple recurrence HCC successfully treated by hepatic resection]. Gan To Kagaku Ryoho 2003 0.75
156 [Three Resected Cases of Metachronous Pancreatic Cancer Successfully Treated with Repeated Pancreatectomy]. Gan To Kagaku Ryoho 2015 0.75
157 [A Case of Axillary Lymph Node Metastases from Distal Bile Duct Cancer]. Gan To Kagaku Ryoho 2016 0.75
158 [Surgical resection and S-1 administration for the treatment of hepatocellular carcinoma]. Gan To Kagaku Ryoho 2012 0.75
159 [A Case of Surgical Resection of a Liver Metastasis from Colorectal Cancer with a Macroscopic Portal Vein Tumor Thrombus]. Gan To Kagaku Ryoho 2015 0.75
160 [The progress of hepatic arterial infusion chemotherapy for hepatocellular carcinoma]. Gan To Kagaku Ryoho 2006 0.75
161 [A case report of hepatectomy for liver metastasis of colon cancer after heavy particle radiotherapy]. Gan To Kagaku Ryoho 2014 0.75
162 [A case report--intrahepatic arterial infusion with CDDP and S-1 administration can elicit long-term survival for the patient with recurrenced intrahepatic cholangiocarcinoma after resection]. Gan To Kagaku Ryoho 2010 0.75
163 [A case of complete response to S-1 therapy for multiple pulmonary recurrences of hepatocellular carcinoma after hepatic resection]. Gan To Kagaku Ryoho 2009 0.75
164 [S-1 treatment against advanced HCC]. Gan To Kagaku Ryoho 2006 0.75
165 [A case of advanced hepatocellular carcinoma with inferior vena cava tumor thrombus and multiple intrahepatic metastases treated successfully by transcatheter arterial chemoembolization and radical hepatectomy]. Gan To Kagaku Ryoho 2012 0.75
166 [Long-term outcomes and risk factors of lymph node metastases in invasive submucosal colorectal cancer]. Gan To Kagaku Ryoho 2014 0.75
167 [A successful case of hepatocellular carcinoma with portal venous tumor thrombus (Vp2) treated by transcatheter arterial chemoembolization]. Gan To Kagaku Ryoho 2006 0.75
168 [A Successful Curative Resection Including Replacement with a Ringed Gore-Tex Tube Graft for Local Recurrence after Right Adrenalectomy and Liver Metastasis of Colon Cancer with Inferior Vena Cava Invasion]. Gan To Kagaku Ryoho 2015 0.75